In the Media

Inside Precision Medicine spotlights Prof. Giovanni Traverso and his team’s work developing an oral drug formulation containing hydrogel that allows for the delivery of small molecules and antibodies via the esophageal mucosal lining. “We were interested in delivering anti-TNFs as a model drug, but also to help people who suffer from conditions like Crohn’s disease to have options that could be delivered to the site,” says Traverso. “If we have the possibility of site-directed delivery, we may be able to mitigate systemic side effects from these immunosuppressing agents.”